S100A9 and cancer: The most recent data on this topic have shown that MSLN can also drive macrophage polarization towards an immunosuppressive phenotype characterized by the secretion of VEGFA, ARG1, and S100A9, thereby stimulating cancer cell growth and weakening the immune response.